Clinical Trial Update: Stem Cell Factor (SCF) Priming of Haematopoietic Stem Cell Grafts in Malignant Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 trial update on stem cell factor (SCF) priming of haematopoietic stem cell grafts in malignant lymphoma, with the study terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Lymphoma

Drugs mentioned

• Stem Cell Factor (SCF) priming of haematopoietic stem cell grafts (Stem Cell Factor (SCF))

Snippet

Sponsor: Aalborg University Hospital | Conditions: Malignant Lymphoma | Phase 2 | Status: TERMINATED